Allison Kwon
Overview
Allison Kwon supports Crowell Health Solutions, a strategic consulting firm affiliated with Crowell & Moring, to help clients pursue and deliver innovative alternatives to the traditional approaches of providing and paying for health care, including through digital health, health equity, and value-based health care. She is a health care policy consultant in the Washington, D.C. office.
Career & Education
- The George Washington University, B.A., 2020
magna cum laude
- The George Washington University, B.A., 2020
Allison 's Insights
Blog Post | 11.26.24
Client Alert | 23 min read | 10.31.24
Blog Post | 10.30.24
CMS Innovation Center Seeks Feedback on Medicare $2 Drug List Model
Blog Post | 09.03.24
Insights
- |
11.28.23
Crowell Health Solutions
RCE Issues Technical Guidance Governing TEFCA Exchange
|11.26.24
Crowell Health Solution’s Trends in Transformation
CMS Innovation Center Seeks Feedback on Medicare $2 Drug List Model
|10.30.24
Crowell Health Solution’s Trends in Transformation
CMS Innovation Center Outlines Data Sharing Principles
|09.03.24
Crowell Health Solution’s Trends in Transformation
HHS Reorganizes ONC and Bolsters AI Leadership
|08.16.24
Crowell Health Solution’s Trends in Transformation
CMS Releases CY 2025 Hospital OPPS Rule and ASC Proposed Rule
|07.29.24
Crowell Health Solution’s Trends in Transformation
- |
07.16.24
Crowell Health Solution’s Trends in Transformation
AHRQ Outlines Principles and Recommendations to Advance Digital Healthcare Equity
|06.06.24
Crowell Health Solution’s Trends in Transformation
Taking a Closer Look at ONC’s AI Transparency Regulations
|05.03.24
Crowell Health Solution’s Trends in Transformation
Senate HELP Committee Ranking Member Issues Health Data Privacy Policy Recommendations
|04.18.24
Crowell Health Solution’s Trends in Transformation
CMS Issues Guidance on HIPAA-Compliant Secure Texting Platforms
|04.03.24
Crowell Health Solution’s Trends in Transformation
Allison 's Insights
Blog Post | 11.26.24
Client Alert | 23 min read | 10.31.24
Blog Post | 10.30.24
CMS Innovation Center Seeks Feedback on Medicare $2 Drug List Model
Blog Post | 09.03.24